Cystatin C Testing Market

Cystatin C Testing Market Overview (2022-2032)

The global cystatin C testing market was valued at around US$ 194.3 Mn at the end of 2021. The market is projected to register a 7.5% CAGR and top a valuation of US$ 400.4 Mn by 2032.

“Launch of various cystatin C testing kits and increasing prevalence of cystatin C-positive disorders among the population across the globe is expected to propel the cystatin C testing market growth.”

The quantity of a protein, cystatin C in the blood is measured by the cystatin C test. Cystatin C is constantly created by the human body, and the protein is detected in several fluids, including spinal fluid, breast milk, and blood. The healthy kidneys sieve cystatin C from the blood so that it can be defecated in the urine.

What are the Major Drivers Boosting the Demand for Cystatin C Testing Market?

The increasing prevalence of several disorders such as myocardial infarction, and muscular dystrophy is one of the major factors that is accelerating the market growth. Besides this, the favorable reimbursement policies in the healthcare sector are a great advantage for cystatin C testing.

Furthermore, the growth in the number of pathology laboratories, hospital laboratories, research labs, and diagnostic centers across the geographies is boosting the market growth for the cystatin C testing market. Apart from this, the low cost of the reagents is also one of the major market stimulating factors. The increased investments in the healthcare sector by the government organizations of several nations are also expected to favor the cystatin C testing market.

Moreover, the major businesses in the market are highly investing in research and development activities, to offer novel and high-quality testing kits and products to the end users such as diagnostic laboratories, clinics, and hospitals. Besides this, the key market players are concentrating on activities like mergers and acquisitions. Due to these activities, the market is expected to grow at a rapid pace in the near future.

Which Region Shows Strong Growth Potential in the Cystatin C Testing Market?

North America held the largest share in the global cystatin C testing market and is expected to continue in the near future. The growing healthcare sector and the launch of novel products in the region are expected to accelerate the market during the forecast period. Europe is also estimated to witness lucrative growth over the projected period, owing to the advanced and developed healthcare facilities.

The increasing disposable income along with the rising health awareness, and increasing demand for diagnostic procedures especially in the geriatric population is the major factor that is expected to fuel the market growth in Asia Pacific Region.

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Who are the Key Manufacturers in the Cystatin C Testing Market?

Some of the key manufacturers operating in the cystatin C testing market are Abbott, Eurolyser Diagnostica, Randox Laboratories, DiaSys Diagnostic Systems, Diazyme Laboratories, Tosoh India Pvt. Ltd., BBI Solutions, PerkinElmer, Siemens Healthcare Private Limited, and Pointe Scientific Inc.

Scope of Report

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Sign-Up

Key Segments Covered in the Cystatin C Testing Industry Survey

By Product:

• Instruments
• Regents
• Kits

By Test:

• Colorimetric Assay Based Tests
• Enzymatic Tests
• Point of Care Tests
• ELISA Based Tests
• Others

By Application:

• Research and Development
• Diagnosis Use

By End User:

• Hospitals
• Clinics
• Diagnostic Laboratories
• Renal Care Centers
• Academic Research Institutes

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia & Pacific
• The Middle East and Africa (MEA)